27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ImmunoGen, Inc. (NASDAQ:IMGN) shares are trading higher by $1.15, or 17 percent, at $7.61 in Tuesday's session.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Before the open, the company announced a strategic collaboration and options agreement with Jazz Pharmaceuticals (NASDAQ:JAZZ) to develop and commercialize antibody-drug conjugate products. Jazz shares are not acting as favorably to the news as the stock is lower by 63 cents at $145.46.
After a higher open, ImmunoGen had only a 4-cent retreat to $6.87 before continuing its move higher. It has moved well into the $7.00 handle as $7.70 stands as the high for the session as of 1:55 p.m. EST. If the rally continues, it will have to contend with a pair of highs from July 7 ($7.88) and July 10 ($7.87) as well as its July 6 high ($8.04).